Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a major global health concern associated with millions of …

SARS-CoV-2 Omicron subvariants have evolved to evade receptor-binding site (RBS)
antibodies that exist in diverse individuals as public antibody clones. We rationally selected …

Objectives In this research, we aimed to find potential factors which are rapidly obtained for
the risk of the coming new variants of severe acute respiratory syndrome coronavirus 2 …

Severe acute respiratory coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019
(COVID-19). The frequent appearance of variants requires adjunct strategies to combat …

SARS-CoV-2 rapidly mutates and acquires resistance to neutralizing antibodies. We report
an in-silico-designed antibody that restores the neutralizing activity of a neutralizing …

We present the clinical course of a 72-year-old female with COVID-19 and a history of
hematologic stem cell transplantation for acute myeloid leukemia. We performed serial …

Breakthrough infection (BI) after coronavirus disease 2019 (COVID-19) vaccination has
exploded owing to the emergence of various SARS-CoV-2 variants and has become a major …

We have previously reported a clinical case in which a hospitalized patient with a history of
hematopoietic stem cell transplantation for acute myeloid leukemia was persistently infected …

抄録 Breakthrough infection (BI) after coronavirus disease 2019 (COVID-19) vaccination has
increased owing to the emergence of novel SARS-CoV-2 variants. In this study, we analyzed …